Combined Effects of Lion's Breath Technique With Chest Percussion Therapy in Pneumonia Patients

Not Applicable

Completed

• Conditions: Pneumonia
• Interventions: Other: Lion's Breath Technique; Other: Chest Percussion Therapy

• Registration Number: NCT06319690
• Lead Sponsor: Riphah International University

Brief Summary

This study will be randomized controlled trial with non-probability convenient sampling. Sample size will be 90,45 in each group. Outcome will be measured by using 6 minute walk test, Spirometry (FVC, FEV1/FVC and PEF), Functional Independence Measure.

Detailed Description

The main objective of the study is to determine the effect of lion's breath technique along with chest percussion therapy in pneumonia patients. This study will be randomized controlled trial with non-probability convenient sampling. Sample size will be 90,45 in each group. Participants included will be adults aged 18 years and above diagnosed with pneumonia. Willing to comply with the study protocol. Both male and female will be included. Participants should be in stable health conditions to participate in the Study. Patients with severe or life-threatening pneumonia requiring immediate intensive care and patients with physical or cognitive limitations. Patients with a history of chronic respiratory conditions such as COPD, bronchitis, or asthma. Pregnant or breastfeeding women. Individuals with musculoskeletal or neurological conditions and Patients with contraindications to chest percussion therapy, such as recent surgery or trauma to the chest area will be excluded. Group A (Lion's Breath Technique + Chest Percussion Therapy) Daily supervised Lion's Breath Technique sessions will be for 20 minutes for 1 week. Trained physiotherapists administer chest percussion therapy will be to mobilize secretions and improve lung function. Daily session for 30 minutes for 1 week. Pre and post data will be gathered. Outcome will be measured by using 6 minute walk test, Spirometry (FVC, FEV1/FVC and PEF), Functional Independence Measure.

Study Timeline

• Study Start: 2024-03-01
• Study First Submitted: 2024-03-04
• Study First Submitted QC: 2024-03-19
• Study First Posted: 2024-03-20
• Primary Completion: 2024-06-05
• Study Completion: 2024-06-15
• Status Verified: 2024-07
• Last Update Submitted: 2024-07-22
• Last Update Posted: 2024-07-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

• Patients in the post-acute phase of pneumonia recovery.
• Adults aged 18 years and above diagnosed with pneumonia.
• Both male and female will be included.
• Participants should be in stable health conditions to participate in the Study.
• Willing to comply with the study protocol

Read More

Exclusion Criteria

• Patients with severe or life-threatening pneumonia requiring immediate intensive care
• Patients with physical or cognitive limitations
• Patients with a history of chronic respiratory conditions such as COPD, bronchitis, or asthma
• Pregnant or breastfeeding women
• Individuals with musculoskeletal or neurological conditions
• Patients with contraindications to chest percussion therapy, such as recent surgery or trauma to the chest area

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Experimental Group (Lion breath)	Lion's Breath Technique	Lion's Breath Technique + Chest Percussion Therapy
Experimental Group (Lion breath)	Chest Percussion Therapy	Lion's Breath Technique + Chest Percussion Therapy
Control Group (Routine treatment)	Chest Percussion Therapy	Chest Percussion Therapy only

Primary Outcome Measures

Name	Time	Method
George respiratory questionnaire	1 Week	The George respiratory questionnaire is Disease-specific instrument designed to measure the impact on overall health, daily life, and perceived well-being in patients with obstructive airways disease. Total 50 items, 2 parts (3 components). Part 1 : Symptoms component (frequency \& severity) with a 1, 3 or 12-month recall (best performance with 3- and 12-month recall); Part 2: Activities that cause or are limited by breathlessness; Impact components (social functioning, psychological disturbances resulting from airways disease) refer to current state as the recall.; Part I (Symptoms): several scales; Part II (Activity and Impacts): dichotomous (true/false) except last question (4-point Likert scale) Scores range from 0 to 100, with higher scores indicating more limitations.
Borg Dyspnea Scale	1 Week	The borg dyspnea scale is a numerical scale that measures the intensity of breathlessness of fatigue. It will be used to assess the baseline and posttest symptoms of patients with respiratory and cardiac condition.; This is a scale that asks you to rate the difficulty of your breathing. It starts at number 0 where your breathing is causing you no difficulty at all and progresses through to number 10 where your breathing difficulty is maximal
Forced expiratory volume (FEV1)	1 Week	Forced expiratory volume (FEV1) calculates the amount of air that a person can force out of their lungs in 1 second. it is measured using Spirometer.
Forced vital capacity (FVC)	1 Week	Forced vital capacity (FVC) is the amount of air that can be forcibly exhaled from your lungs after taking the deepest breath possible. It's measured by spirometry
FEV1/FVC Ratio	1 Week	The FEV1/FVC ratio is the ratio of the forced expiratory volume in the first one second to the forced vital capacity of the lungs. The normal value for this ratio is above 0.75-85, measured using Spirometer.

Trial Locations

Locations (1)

Jinnah Hospital; 🇵🇰 Lahore, Punjab, Pakistan